155 related articles for article (PubMed ID: 33882650)
1. [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children].
Karaaslan E; Çetin Ş
Mikrobiyol Bul; 2021 Apr; 55(2):180-193. PubMed ID: 33882650
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
5. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
Kalın G; Metan G; Demiraslan H; Doganay M
J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
[TBL] [Abstract][Full Text] [Related]
6. EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA.
Vashakidze E; Mikadze I
Georgian Med News; 2015 Oct; (247):54-8. PubMed ID: 26483375
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of children with Crimean-Congo hemorrhagic fever in the central Blacksea region.
Belet N; Top A; Terzi O; Arslan HN; Baysal K; Sensoy G
Pediatr Infect Dis J; 2014 Aug; 33(8):e194-7. PubMed ID: 24463803
[TBL] [Abstract][Full Text] [Related]
8. Crimean-Congo hemorrhagic fever in children.
Tezer H; Sucakli IA; Sayli TR; Celikel E; Yakut I; Kara A; Tunc B; Ergonul O
J Clin Virol; 2010 Jul; 48(3):184-6. PubMed ID: 20444644
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
10. Big Epidemic of Small City: Crimean-Congo Hemorrhagic Fever.
Doğan E; Özer Kökkızıl S; Esen M; Kayalı S
Turkiye Parazitol Derg; 2023 Dec; 47(4):229-234. PubMed ID: 38149444
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Simultaneous Acute Lymphoblastic Leukemia Diagnosis with Crimean-Congo Hemorrhagic Fever].
Çayıröz P; Çayıröz MU; Iltar U; Kurtoğlu E
Mikrobiyol Bul; 2020 Apr; 54(2):326-333. PubMed ID: 32723287
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.
Gozdas HT
Afr Health Sci; 2019 Mar; 19(1):1433-1440. PubMed ID: 31148970
[TBL] [Abstract][Full Text] [Related]
17. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
19. Transient sinus bradycardia during the course of Crimean-Congo hemorrhagic fever in children.
Gayretli Aydin ZG; Tanir G; Metin O; Aydin Teke T; Bayhan GI; Oz FN; Caglayik DY; Gençtürk Z
Ticks Tick Borne Dis; 2015 Mar; 6(2):185-8. PubMed ID: 25555370
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.
Duran A; Küçükbayrak A; Ocak T; Hakyemez NI; Taþ T; Karadađ M; Mengelođlu ZF
Afr Health Sci; 2013 Jun; 13(2):233-42. PubMed ID: 24235918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
